On November 29th, the renowned French market research company Reportlinker released a report titled "Global Smoking Cessation and Nicotine Cessation Market 2023-2027".
Photo credit: ReportLinker.
From 2023 to 2027, it is expected that the global smoking cessation and nicotine replacement therapy market will grow by $24.53 billion (approximately RMB 175.42 billion), with an annual compound growth rate of 12.59% during the forecast period. The report provides an overall analysis, market size and forecasts, trends, growth drivers and challenges, as well as supplier analysis covering approximately 25 suppliers.
This study has brought new marketing strategies and opportunities for the e-cigarette industry, potentially driving rapid growth in the smoking cessation and nicotine replacement markets in the coming years.
Furthermore, an increasing number of retail stores are selling nicotine patches and utilizing various distribution channels to increase their popularity, which is expected to result in a high market demand.
2FIRSTS will continue to cover this topic and provide updates on the '2FIRSTS APP'. Scan the QR code below to download the app for further information.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
